Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX)

Q: What does CUSIP M40527109 represent in this 13F holders report?

CUSIP M40527109 is the security identifier for ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share used to aggregate holder disclosures.

Q: How many institutions held ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share in Q3 2024?

17 institutional investors reported ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: M40527109

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Ordinary shares, par value NIS 0.0000769 per share
Shares outstanding: 45,504,462
Total 13F shares: 5,323,228
Share change: +30,239
Total reported value: $10,112,228
Put/Call ratio: 3.8%
Reported price per share: $1.90
Number of holders: 17
Value change: +$57,454
Number of buys: 6
Number of sells: 3

Security key

M40527109

Report period

Q3 2024

Institutions

Top holders

ENTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2024 Previous quarter: Q2 2024 Entera Bio Ltd. SEC filings Entera Bio Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP M40527109

Newer quarter: Q4 2024 Previous quarter: Q2 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Knoll Capital Management,...

13D/G signal

—

Evidence rows

Latest as of

30 Jun 2024

13F 3/4/5 Lead comparable stake: 8.5% Showing 1-6 of 15 holder rows.

Rank 1 holder

Knoll Capital Management, LLC

13F

Ownership: 8.5%
Position: $7.14M

13F

Rank 2 holder

Schonfeld Strategic Advisors LLC

13F

Ownership: 1.5%
Position: $1.24M

13F

Rank 3 holder

Parkman Healthcare Partners LLC

13F

Ownership: 0.88%
Position: $738.8K

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Knoll Capital Management, LLC	13F Company 13F	8.5%	$7,142,657 3,881,879 shares	—	30 Jun 2024
Schonfeld Strategic Advisors LLC	13F Company 13F	1.5%	$1,236,034 671,758 shares	—	30 Jun 2024
Parkman Healthcare Partners LLC	13F Company 13F	0.88%	$738,793 401,518 shares	—	30 Jun 2024
UBS Group AG	13F Company 13F	0.37%	$308,426 167,623 shares	—	30 Jun 2024
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.13%	$105,984 57,600 shares	—	30 Jun 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	0.06%	$53,095 28,856 shares	—	30 Jun 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,323,228

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend